Literature DB >> 23909011

Global Advisory Committee on Vaccine Safety,12–13 June 2013.

.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23909011

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  12 in total

Review 1.  Human papillomavirus vaccination: a case study in translational science.

Authors:  Allyson K Palmer; Antoneicka L Harris; Robert M Jacobson
Journal:  Clin Transl Sci       Date:  2014-05-19       Impact factor: 4.689

Review 2.  Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer.

Authors:  Rebecca Luckett; Sarah Feldman
Journal:  Hum Vaccin Immunother       Date:  2015-11-20       Impact factor: 3.452

Review 3.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

Review 4.  Revised adult immunization guideline recommended by the korean society of infectious diseases, 2014.

Authors:  Won Suk Choi; Jung-Hyun Choi; Ki Tae Kwon; Kyung Seo; Min A Kim; Sang-Oh Lee; Young Jin Hong; Jin-Soo Lee; Joon Young Song; Ji Hwan Bang; Hee-Jung Choi; Young-Hwa Choi; Dong Gun Lee; Hee Jin Cheong
Journal:  Infect Chemother       Date:  2015-03-30

5.  Revised World Health Organization (WHO)'s causality assessment of adverse events following immunization-a critique.

Authors:  Jacob Puliyel; Pathik Naik
Journal:  F1000Res       Date:  2018-02-28

6.  Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study.

Authors:  Giuseppe Mastrangelo; Sofia Pavanello; Emanuela Fadda; Alessandra Buja; Ugo Fedeli
Journal:  Eur J Cancer Prev       Date:  2018-07       Impact factor: 2.497

7.  The Costs of Contradictory Messages About Live Vaccines in Pregnancy.

Authors:  Elana Jaffe; Ilona Telefus Goldfarb; Anne Drapkin Lyerly
Journal:  Am J Public Health       Date:  2021-01-21       Impact factor: 9.308

Review 8.  Post-licensure safety surveillance for human papillomavirus-16/18-AS04-adjuvanted vaccine: more than 4 years of experience.

Authors:  Maria-Genalin Angelo; Julia Zima; Fernanda Tavares Da Silva; Laurence Baril; Felix Arellano
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-02-20       Impact factor: 2.890

9.  Detectable Risks in Studies of the Fetal Benefits of Maternal Influenza Vaccination.

Authors:  Jennifer A Hutcheon; Deshayne B Fell; Michael L Jackson; Michael S Kramer; Justin R Ortiz; David A Savitz; Robert W Platt
Journal:  Am J Epidemiol       Date:  2016-06-30       Impact factor: 4.897

10.  Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.

Authors:  María Paz-Zulueta; Ledicia Álvarez-Paredes; Juan Carlos Rodríguez Díaz; Paula Parás-Bravo; Ma Encarnación Andrada Becerra; José María Rodríguez Ingelmo; María Montserrat Ruiz García; Joaquín Portilla; Miguel Santibañez
Journal:  BMC Cancer       Date:  2018-01-30       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.